The study utilizes Hain GenoType MTBDR assays to uncover that certain mutations can lead to incorrect resistance results for fluoroquinolones, impacting both wild-type and mutant probe binding.
These mutations, while rare worldwide, are present in about 7% of multidrug-resistant tuberculosis strains in specific areas.
This finding highlights the need for careful interpretation of assay results in TB treatment to ensure accurate resistance detection.